Cargando…
P946: A PHASE I/II SINGLE ARM STUDY OF BELANTAMAB MAFODOTIN, CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA: AMARC 19-02 BELACARD STUDY.
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430338/ http://dx.doi.org/10.1097/01.HS9.0000846652.51254.ac |
| _version_ | 1784779739949432832 |
|---|---|
| author | Lasica, M. Spencer, A. Campbell, P. Wallington-Gates, C. Wong Doo, N. Janowski, W. McCaughan, G. Puliyayil, A. Yuen, F. Le, K. Reynolds, J. Quach, H. |
| author_facet | Lasica, M. Spencer, A. Campbell, P. Wallington-Gates, C. Wong Doo, N. Janowski, W. McCaughan, G. Puliyayil, A. Yuen, F. Le, K. Reynolds, J. Quach, H. |
| author_sort | Lasica, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430338 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94303382022-08-31 P946: A PHASE I/II SINGLE ARM STUDY OF BELANTAMAB MAFODOTIN, CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA: AMARC 19-02 BELACARD STUDY. Lasica, M. Spencer, A. Campbell, P. Wallington-Gates, C. Wong Doo, N. Janowski, W. McCaughan, G. Puliyayil, A. Yuen, F. Le, K. Reynolds, J. Quach, H. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430338/ http://dx.doi.org/10.1097/01.HS9.0000846652.51254.ac Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Lasica, M. Spencer, A. Campbell, P. Wallington-Gates, C. Wong Doo, N. Janowski, W. McCaughan, G. Puliyayil, A. Yuen, F. Le, K. Reynolds, J. Quach, H. P946: A PHASE I/II SINGLE ARM STUDY OF BELANTAMAB MAFODOTIN, CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA: AMARC 19-02 BELACARD STUDY. |
| title | P946: A PHASE I/II SINGLE ARM STUDY OF BELANTAMAB MAFODOTIN, CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA: AMARC 19-02 BELACARD STUDY. |
| title_full | P946: A PHASE I/II SINGLE ARM STUDY OF BELANTAMAB MAFODOTIN, CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA: AMARC 19-02 BELACARD STUDY. |
| title_fullStr | P946: A PHASE I/II SINGLE ARM STUDY OF BELANTAMAB MAFODOTIN, CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA: AMARC 19-02 BELACARD STUDY. |
| title_full_unstemmed | P946: A PHASE I/II SINGLE ARM STUDY OF BELANTAMAB MAFODOTIN, CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA: AMARC 19-02 BELACARD STUDY. |
| title_short | P946: A PHASE I/II SINGLE ARM STUDY OF BELANTAMAB MAFODOTIN, CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA: AMARC 19-02 BELACARD STUDY. |
| title_sort | p946: a phase i/ii single arm study of belantamab mafodotin, carfilzomib and dexamethasone in patients with relapsed multiple myeloma: amarc 19-02 belacard study. |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430338/ http://dx.doi.org/10.1097/01.HS9.0000846652.51254.ac |
| work_keys_str_mv | AT lasicam p946aphaseiiisinglearmstudyofbelantamabmafodotincarfilzomibanddexamethasoneinpatientswithrelapsedmultiplemyelomaamarc1902belacardstudy AT spencera p946aphaseiiisinglearmstudyofbelantamabmafodotincarfilzomibanddexamethasoneinpatientswithrelapsedmultiplemyelomaamarc1902belacardstudy AT campbellp p946aphaseiiisinglearmstudyofbelantamabmafodotincarfilzomibanddexamethasoneinpatientswithrelapsedmultiplemyelomaamarc1902belacardstudy AT wallingtongatesc p946aphaseiiisinglearmstudyofbelantamabmafodotincarfilzomibanddexamethasoneinpatientswithrelapsedmultiplemyelomaamarc1902belacardstudy AT wongdoon p946aphaseiiisinglearmstudyofbelantamabmafodotincarfilzomibanddexamethasoneinpatientswithrelapsedmultiplemyelomaamarc1902belacardstudy AT janowskiw p946aphaseiiisinglearmstudyofbelantamabmafodotincarfilzomibanddexamethasoneinpatientswithrelapsedmultiplemyelomaamarc1902belacardstudy AT mccaughang p946aphaseiiisinglearmstudyofbelantamabmafodotincarfilzomibanddexamethasoneinpatientswithrelapsedmultiplemyelomaamarc1902belacardstudy AT puliyayila p946aphaseiiisinglearmstudyofbelantamabmafodotincarfilzomibanddexamethasoneinpatientswithrelapsedmultiplemyelomaamarc1902belacardstudy AT yuenf p946aphaseiiisinglearmstudyofbelantamabmafodotincarfilzomibanddexamethasoneinpatientswithrelapsedmultiplemyelomaamarc1902belacardstudy AT lek p946aphaseiiisinglearmstudyofbelantamabmafodotincarfilzomibanddexamethasoneinpatientswithrelapsedmultiplemyelomaamarc1902belacardstudy AT reynoldsj p946aphaseiiisinglearmstudyofbelantamabmafodotincarfilzomibanddexamethasoneinpatientswithrelapsedmultiplemyelomaamarc1902belacardstudy AT quachh p946aphaseiiisinglearmstudyofbelantamabmafodotincarfilzomibanddexamethasoneinpatientswithrelapsedmultiplemyelomaamarc1902belacardstudy |